Your Location:
Home >
Browse articles >
Bufei Tongbi Decoction Inhibits Pulmonary Fibrosis in Diabetic Rats via TGF-β 1/p-Smad3 Signaling Pathway
Bufei Tongbi Decoction Inhibits Pulmonary Fibrosis in Diabetic Rats via TGF-
β 1/p-Smad3 Signaling Pathway- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 10, Pages: 176-184(2025)
DOI: 10.13422/j.cnki.syfjx.20241518
Accepted:20 March 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 2 ) Tabs( 7 )
References
Publication Info
Metrics
509
Views
426
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Jinshui Huanxian Component Formula Ⅱ Combined with Matrix Softening in Ameliorating Pulmonary Fibrosis Through Inhibition of Epithelial-mesenchymal Transition
Role of Fluid Shear Stress in Pulmonary Fibrosis from Perspective of Lung Linking with All Vessels
Effect and Mechanisms of Bushen Tongluo Prescription on Pulmonary Fibrosis via Inhibiting Macrophage Polarization Through Wnt3a/β-catenin Signaling Pathway
A Systematic Strategy for Discovering First-in-class Anti-fibrotic Drugs from Traditional Chinese Medicine
Expert Consensus on Clinical Application of SkinPro Ointment
Related Author
WANG Gang
ZHANG Dan
CHEN Xin
WU Xiaojie
LI Mingyan
KUANG Shiyu
PENG Xiling
HOU Xiaorong
Related Institution
Zigong First People's Hospital
Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Ministry of Education of China, Academy of Chinese Medical Sciences, Henan University of Chinese Medicine
Academy of Chinese Medical Sciences, Hunan University of Chinese Medicine
Medical School, Hunan University of Chinese Medicine
College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine


